Seeking Alpha

Here’s the entire text of the prepared remarks from China Medical Technologies’ (ticker: CMED) Q3 2005 conference call. The Q&A is here. We recognize that this transcript may contain inaccuracies - if you find any, please post a comment below and we’ll incorporate your corrections. And please note: this conference call transcript is a Seeking Alpha product, so feel free to link to it but reproduction is not permitted without the explicit permission of Seeking Alpha.

Executives:

Tip Fleming, Investor Relations Advisor, Christensen
Charles Zhu, Vice President, Business Development and Investor Relations
Sam Tsang, Chief Financial Officer

Analysts:

Richard Lou (ph), RJC Capital Management (ph)
Weidong Huang, TimesSquare Capital Management
Matt Wyden (ph), Stafford Capital (ph)
Patrick Lin, Primarius Capital

Presentation

Operator

Good day and welcome ladies and gentlemen to the September China Medical Technologies Earnings Conference Call. My name is Audrey and I will be your coordinator for today. At this time, all participants are in a listen-only mode. We will be facilitating a question and answer session towards the end of this conference. If at any time during the call, you require assistance press “*

Latest articles on CMED

Search This Transcript: